市場概況

The Europe vaccine packaging market exhibited a value of $1,016.6 百万で 2022 and is expected to reach $1,487.4 百万までに 2028, 年間複利成長率 (CAGR) の 6.55% 勉強期間中に.

Vaccine packaging plays a crucial role in securely packaging vaccines to maintain their therapeutic potency for a specific duration. It encompasses various packaging components such as vials, アンプル, prefilled syringes, そしてバッグ & ポーチ, serving as the primary level of packaging.

As a result of these favorable conditions, the vaccine packaging market in Europe is poised for continued expansion in the coming years.

市場セグメンテーション

市場はさまざまな要因に基づいて分割されます, including packaging level, 包装タイプ, 材料の種類, エンドユーザータイプ, と地域.

Segmentation by Packaging Level
主要な
二次
三次

パッケージングタイプによるセグメンテーション
バイアル
アンプル
注射器
その他

材料タイプによるセグメンテーション
ガラス
プラスチック
その他

エンドユーザーのタイプ別のセグメンテーション
医薬品 & バイオテクノロジー企業
Healthcare Facilities
その他

地域ごとのセグメンテーション
Eu5- ドイツ, フランス, イギリス, イタリア, スペイン
中央 & 東ヨーロッパ – ポーランド, オランダ, スイス
Nordic Countries – スウェーデン, デンマーク

The primary packaging segment holds the largest share, 超える 71%, in Europe’s vaccine packaging market. This is primarily driven by the increasing demand for vials, アンプル, and syringes due to the growing need for vaccines.

Among the different types of primary packaging, vials packaging captures the majority market share in the Europe vaccine packaging market, を説明する 38.18%. This dominance can be attributed to the widespread utilization of vials as essential primary packaging components for vaccine products.

素材の種類でいうと, glass emerges as the leading segment, capturing a share of 44.09% in the Europe vaccine packaging market. This can be attributed to the external barrier properties of glass and its high demand for primary packaging purposes.

Within the Europe vaccine packaging market, pharmaceutical and biotech companies hold the largest share, 超える 46%. This growth is propelled by factors such as the rise in contagious or infectious diseases, the aging population, and the increasing demand for vaccines. さらに, innovations in vaccine development have further spurred the growth of the vaccine packaging industry.

の 2022, the EU5 countries (イギリス, ドイツ, フランス, イタリア, スペイン) dominate the vaccine packaging market, holding the highest revenue share of 53.76%. Central and Eastern Europe follow with a share of 35.37%, while the Nordic countries account for 10.87% 市場シェアの.

競争環境

The competitive landscape in the European vaccine packaging market is becoming increasingly intense, as global players offer a wide range of products. 現在, several companies dominate the vaccine packaging market in Europe, including SCHOTT, ゲレスハイマーAG, Stevanato Group, アムコール, SGD Pharma, WestRock, Corning Incorporation, その他.

Key companies profiled in this report include SCHOTT Pharma, ゲレスハイマーズ AG, Stevanato Group, SGD Pharma, WestRock Pharma, アムコール, アプターグループ, Corning International, キャタレント, ベクトン, ディキンソンと仲間たち (BD), Panasonic Health Corporation, Cognex, 11月の空気, ビルケア研究, DHL, ボロシル, CCL, 医薬品プラスチックグループ, DWK ライフサイエンス, ログ, Eppendorf, ルノー, Qorpak, ニプロ, Medical Packaging LLC.

主な質問への回答

What was the market size of the vaccine packaging market in Europe in 2022?

What are the significant trends influencing the growth of the vaccine packaging market in Europe?

Who are the key players in the vaccine packaging market in Europe?

Which packaging type segment holds the largest market share in the vaccine packaging market in Europe?

Which European country has the highest market share in the vaccine packaging market in Europe?

How is each segment of the vaccine packaging market expected to grow during the forecast period?

What will be the compound annual growth rate (CAGR) of the vaccine packaging market in Europe during the forecast period?

Which primary packaging type holds a stronger market share in the vaccine packaging market in Europe?

What is the major end-user type segment in the vaccine packaging market in Europe?

What are the driving factors, 拘束, and opportunities in the vaccine packaging market in Europe?